Biotechnology firms accounted for 30% of the top 25 leases during Q4 2020, expanding their footprint with several significant lease transactions. Sales volume exceed $911 million as investors, developers, and users were all represented.
You have reached your report download limit for today. Please return later to access further reports. If you believe this is incorrect please contact [email protected]